ASLAN Pharmaceuticals Ltd — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$12.0M

Net Income/Loss (FY2023)

-$44.2M

Total Assets (FY2023)

$24.6M

Total Equity (FY2023)

-$13.3M

Cash Flows from Operating Activities (FY2023)

-$46.6M

Source: ASLAN Pharmaceuticals Ltd 20-F filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.